跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACH-APIXABAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACH-APIXABAN
Authorized
STANDARD
ACH-APIXABAN
Accord Healthcare Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7859ab9959c749b2
Company
Accord Healthcare Inc
Type
Standard
Approval Details
Approval Id
7859ab9959c749b2
Drug Approval Canada Name
ACH-APIXABAN
Product Name
ACH-APIXABAN
Status
Marketed
Status Date
2022-09-27
Original Market Date
2022-09-27
Din
02487713
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
20:12.04.14
Atc Original
B01AF02 APIXABAN
Atc Name
b 01 af 02
Aig Number
0153051001
Company Name
Accord Healthcare Inc
Company Address
3535 Boulevard St-Charles, Suite 704, Kirkland, Quebec, Canada, H9H 5B9
Company Detail Path
/organization/accord-healthcare-inc
Company Information
Pharmaceutical Company Name
Accord Healthcare Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
704-3535 boul Saint-Charles
Active Ingredients
APIXABAN
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7859ab9959c749b2
Type
Standard
Back to Health Canada Approvals